SilverArc Private — Full Portfolio

3 tracked investments · listed companies and verified rows first

ADARx Pharmaceuticals, Inc.Aug 2023SEC filingmedium confidence

San Diego, US

Board seatSheila Gujrathi· per SEC Form D · $200M raise · filed Aug 2023

Lila Biologics, Inc.Sep 2023SEC filingmedium confidence

BiotechSeattle, US

William Canestaro(Director)Sheila Gujrathi(Director)John Kraft, II(Executive Officer, Director)Anindya Roy(Executive Officer, Director)

Board seatSheila Gujrathi· per SEC Form D · $10.6M raise · filed Sep 2023

Ventyx Biosciencesventyxbio.comSep 2024SEC filingmedium confidence

San Diego, US

Mark S. Forman(Executive Officer)Matthew Moore(Executive Officer)John Nuss(Executive Officer)Jigar Choksey(Director)Martin Auster(Executive Officer)Christopher W. Krueger(Executive Officer)

Board seatSheila Gujrathi· per SEC Form D · $27M raise · filed Sep 2024

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.